@Trisha_the_doc It’s a highly cost effective intervention at €7500/QALY (compared with surgery for a primary brain tumour at >£200k/QALY) yet rarely offered as a treatment option - most commonly due to a failure of clinicians to recognise patients who m
RT @ag_kolias: Data from Sweden on cost utility of shunts for #iNPH - decision analytic model #CSF #neurosurgery #nsgy @Claudia_Craven @P…
RT @ag_kolias: Data from Sweden on cost utility of shunts for #iNPH - decision analytic model #CSF #neurosurgery #nsgy @Claudia_Craven @P…
RT @ag_kolias: Data from Sweden on cost utility of shunts for #iNPH - decision analytic model #CSF #neurosurgery #nsgy @Claudia_Craven @P…